Establishment of DXDMED (Japan), Japanese Medical Device Export Joint Venture

NovoTec (Singapore) and Neustadt (Japan)

Establishment of DXDMED (Japan), Japanese Medical Device Export Joint Venture

On March 21, 2025, NovoTec Group Pte. Ltd. (“NovoTec”, head office: Singapore, Director: Motonori Imaseki) and Neustadt Japan Co., Ltd. (“Neustadt”, head office: Tokyo, Representative Director: Kazuyoshi Suzuki) agreed to invest and establish DXDMed Inc. (“DXDMED”, head office: Tokyo) as a joint venture with a primary purpose of exporting medical devices, and entered into an investment and other definitive agreements (the “Project”).

<Background and Purpose of the Project>

NovoTec is a Singapore headquartered company that invests in and manages healthcare technology businesses, and operates businesses through its group companies in Singapore, Malaysia and the U.S. NovoTec received the investment from Toyo Seikan Group Holdings Co., Ltd. (code number 5901) ("Toyo Seikan Group ", head office: Tokyo, President and Representative Director: Kazuo Otsuka), listed on the Tokyo Stock Exchange ("TSE"), in April 2023 for the purpose of promoting Toyo Seikan Group’s business creation and exploration of entry opportunities in the healthcare field.

Neustadt is a Japanese company founded by Kazuyoshi Suzuki, a dentist and inventor as well as former banker, and is engaged in the development, manufacture, and sale of medical devices for dentists, such as Kitsutsuki (woodpecker) Contra (see <Kitsutsuki Contra Overview> below) in Japan. Neustadt has won many awards, including the Grand Prize in the Product / Technology (Venture Technology) category at the Global Innovation Competition (2019) organized by the Tokyo Metropolitan Small and Medium Enterprise Support Center, for Kitsutsuki Contra, and continues to develop innovative medical devices.

NovoTec deeply resonates with Neustadt's corporate mission of "Aim to contribute to the development of dental care around the world by bringing together the wisdom of Japanese dentists!", and the both companies agreed to establish DXDMED as a joint venture in Japan to promote the export of Neustadt's medical devices. With this background, DXDMED's corporate mission is "Make a Dent in the World!", and as a global-oriented company since its founding, it has added DXD (Di-By-Di) to its company name with the aim of exporting high-quality and reliable "Device By Doctor" medical devices based on innovative Japanese technology from Japan to the world (see company logo below). DXDMED aims to promote its business with the goal of forming a platform to promote and provide not only Neustadt products but also other excellent medical devices and medical services from other Japanese venture companies and small and medium-sized enterprises to the world, and intends to be listed on the TSE or other markets in approximately five years.

(DXDMED company logo)

＜Overview of Kitsutsuki Contra＞

Root canal treatment (treatment of the root canal when tooth decay has progressed to the pulp and caused inflammation and infection) which was previously performed by the dentist's hand movements (usually about 60 up and down movements per minute) has been mechanized and automated based on patented technology, and this revolutionary dental device performs root canal treatment with speed and precision that is difficult to achieve by hand, with up and down movements of about 50,000 to 100,000 times per minute. It was named "Kitsutsuki” (woodpecker) Contra because of its up and down movement, rather than the drill rotation movement of normal dental devices.

<Comments from Related Parties>

Motonori Imaseki (NovoTec): "NovoTec is honored to collaborate with Neustadt through DXDMED. This initiative is in line with the goals of the "White Paper on Strengthening Japan’s Healthcare Startup Ecosystem” (Team Leader: Akihisa Shiozaki, Parliamentary Vice-Minister of Health, Labour and Welfare) published by the Japanese Ministry of Health, Labour and Welfare in May 2024, which aims to promote the export of medical devices with innovative Japanese technology. DXDMED also hopes to build relationships with other Japanese medical device-related companies in addition to Neustadt depending on future business opportunities, and jointly promote the overseas expansion of Japan's excellent medical devices and medical services."

Kazuyoshi Suzuki (Neustadt): " In Japan, the Ministry of Health and Welfare (currently the Ministry of Health, Labor and Welfare) launched the "8020 Campaign" about 35 years ago in 1989. This campaign had the goal of "maintaining 20 or more of one's own teeth even at the age of 80," which was the average life expectancy of Japanese people at the time. It was believed that if a person has 20 or more teeth, he/she would be able to be satisfied with his/her foods consumptions. Therefore, the campaign was intended to convey the wish that people would be able to "enjoy eating with their own teeth for the rest of their lives." Maintaining sufficient chewing function also reduces the burden on the digestive organs, and is considered to be one of the factors behind the longevity of Japanese people. As the average life expectancy of the world is about 73 years as of 2024, and as life expectancy continues to increase, I believe that keeping the person's own teeth, eating delicious food, and living a long and healthy life will lead to happiness not only in Japan but also around the world. Therefore, I believe that treatment to protect the person's own teeth, especially with root canal treatment, plays an important role. I am very pleased to have the opportunity to collaborate with NovoTec and promote to expand Japanese dental systems into overseas, which will contribute to the development of dental care around the world. With my objectives to realize high-quality dental care at a reasonable cost around the world, I will continue to develop and promote new dental medical equipment."

Toyo Seikan Group's [ Name (Title)] : "For us, this is a very significant project that NovoTec, one of our investment companies, is collaborating with Neustadt, an innovative Japanese medical device company, to start an export joint venture in Japan. [In addition, our company operates a business that is closely linked to food and health through canned products and other packaged products, and from that perspective, we view this project as having a social impact on dental care and food health.] [In terms of exploring business creation and entry opportunities in the future healthcare field, we would like to discuss the collaboration possibility with Neustadt and DXDMED through NovoTec in the future.]"

＜Company Profile＞

Overview of NovoTec

Company Name	NovoTec Group Pte. Ltd.
address	Level 39, Marina Bay Financial Center Tower 2, 10 Marina Boulevard, Singapore 018983
Director	Motonori Imaseki , J. Sang Edward , etc.
Established	April 2023
Main Business	Investment and management in the healthcare technology business and the operation of such business by its group companies
Subsidiaries and Affiliates	Singapore, Malaysia, United States
Website	www.novotecgrp.com

Overview of Neustadt

Company Name	Neustadt Japan Co., Ltd.
Representative Director	Kazuyoshi Suzuki
address	7-13-1 Minamikoiwa, Edogawa-ku, Tokyo
Established	April 1996
Main Business	Development, manufacturing and sales of medical equipment for dentists such as Kitsutsuki Contra
Website	www.neustadtjapan.com

Overview of DXDMED

Company Name	DXDMed Inc.
Representative Director (scheduled)	Motonori Imaseki and Kazuyoshi Suzuki
address	Yebisu Garden Place Tower 18th floor, 4-20-3 Ebisu, Shibuya-ku, Tokyo
Established	January 2025
Ownership (scheduled)	NovoTec 51%, Neustadt 49%
Main business	Export of medical devices, etc.
Website	www.dxdmed.com

<Contact for inquiries regarding this matter>

DXDMed Inc.

Contact Person: Motomi Takayama

Phone: 03-XXXX-XXXX

Email: info@dxdmed.com